Add like
Add dislike
Add to saved papers

Synthesis and Characterization of High-Energy Anti -Perovskite Compounds Cs 3 X [B 12 H 12 ] Based on Cesium Dodecahydro- Closo -Borate with Molecular Oxoanions ( X - = [NO 3 ] - , [ClO 3 ] - and [ClO 4 ] - ).

Three novel anti -perovskite compounds, formulated as Cs3 X [B12 H12 ] ( X- = [NO3 ]- , [ClO3 ]- , and [ClO4 ]- ), were successfully synthesized through the direct mixing of aqueous solutions containing Cs2 [B12 H12 ] and Cs X ( X- : [NO3 ]- , [ClO3 ]- , [ClO4 ]- ), followed by isothermal evaporation. All three compounds crystallize in the orthorhombic space group Pnma , exhibiting relatively similar unit-cell parameters (e.g., Cs3 [ClO3 ][B12 H12 ]: a = 841.25(5) pm, b = 1070.31(6) pm, c = 1776.84(9) pm). The crystal structures were determined using single-crystal X-ray diffraction, revealing a distorted hexagonal anti -perovskite order for each. Thermal analysis indicated that the placing oxidizing anions X - into the 3 Cs+ + [B12 H12 ]2- blend leads to a reduction in the thermal stability of the resulting anti -perovskites Cs3 X [B12 H12 ] as compared to pure Cs2 [B12 H12 ], so thermal decomposition commences at lower temperatures, ranging from 320 to 440 °C. Remarkably, the examination of the energy release through DSC studies revealed that these compounds are capable of setting free a substantial amount of energy, up to 2000 J/g, upon their structural collapse under an inert-gas atmosphere (N2 ). These three compounds represent pioneering members of the first ever anti -perovskite high-energy compounds based on hydro- closo -borates.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app